Avlocardyl
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
381 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | 4 | 12 | 10 | 17 | 40 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 4 | 13 | 5 | 7 | 3 | 29 |
| Fibrosis | D005355 | — | — | — | 3 | 7 | 7 | 14 | 28 |
| Esophageal and gastric varices | D004932 | EFO_0009545 | I85 | 1 | — | 7 | 8 | 9 | 25 |
| Hemangioma | D006391 | — | D18.0 | 1 | 9 | 6 | 4 | 7 | 24 |
| Traumatic stress disorders | D040921 | — | — | 3 | 11 | 4 | 4 | 3 | 23 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | 1 | 2 | 7 | 2 | 12 | 22 |
| Migraine disorders | D008881 | EFO_0003821 | G43 | — | 3 | 5 | 8 | 5 | 20 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 3 | 7 | 2 | 7 | 17 |
| Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 2 | 4 | 5 | 6 | 17 |
Show 76 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 11 | 3 | 1 | — | 5 | 19 |
| Retinal diseases | D012164 | HP_0000479 | H35.9 | 2 | 6 | 1 | — | 1 | 8 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | 6 | 1 | — | 1 | 7 |
| Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | 1 | 6 | 1 | — | 1 | 7 |
| Burns | D002056 | — | T30.0 | — | 6 | 5 | — | 1 | 7 |
| Melanoma | D008545 | — | — | 3 | 4 | 1 | — | — | 6 |
| Thrombosis | D013927 | — | — | — | — | 2 | — | 3 | 5 |
| Venous thrombosis | D020246 | HP_0004936 | I82.40 | — | — | 2 | — | 3 | 5 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | 1 | — | 3 | 4 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | 1 | 2 | — | 1 | 4 |
Show 36 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cocaine-related disorders | D019970 | — | F14 | 2 | 4 | — | — | 1 | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 3 | — | — | 1 | 5 |
| Orthostatic intolerance | D054971 | — | — | 2 | 1 | — | — | 2 | 4 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 2 | 4 |
| Autistic disorder | D001321 | HP_0000717 | F84.0 | 1 | 1 | — | — | 2 | 4 |
| Sarcoma | D012509 | — | — | — | 4 | — | — | — | 4 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 1 | — | — | 1 | 3 |
| Hypoglycemia | D007003 | HP_0001943 | E16.2 | 1 | 1 | — | — | 1 | 3 |
| Adenocarcinoma | D000230 | — | — | 1 | 2 | — | — | — | 3 |
| Hemangiosarcoma | D006394 | — | — | 1 | 3 | — | — | — | 3 |
Show 86 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ovarian epithelial carcinoma | D000077216 | — | — | 3 | — | — | — | 1 | 4 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | — | — | — | 1 | 3 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 2 | — | — | — | 1 | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | — | — | — | 1 | 3 |
| Fallopian tube neoplasms | D005185 | — | — | 2 | — | — | — | 1 | 3 |
| Memory | D008568 | — | — | 1 | — | — | — | 1 | 2 |
| Hypoxia | D000860 | HP_0012418 | R09.02 | 2 | — | — | — | — | 2 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | — | — | — | — | 1 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | — | — | — | — | 1 |
| Stem cell transplantation | D033581 | — | — | 1 | — | — | — | — | 1 |
Show 36 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | — | — | — | 2 | 2 |
| Surgical portasystemic shunt | D011170 | — | — | — | — | — | — | 2 | 2 |
| Tympanic membrane perforation | D018058 | — | H72 | — | — | — | — | 1 | 1 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
| Drug interactions | D004347 | — | — | — | — | — | — | 1 | 1 |
| Insulin resistance | D007333 | HP_0000855 | — | — | — | — | — | 1 | 1 |
| Vestibular diseases | D015837 | EFO_0009691 | H81 | — | — | — | — | 1 | 1 |
| Orthodontic extrusion | D050793 | — | — | — | — | — | — | 1 | 1 |
| Exercise test | D005080 | EFO_0004328 | — | — | — | — | — | 1 | 1 |
| Transjugular intrahepatic portasystemic shunt | D019168 | — | — | — | — | — | — | 1 | 1 |
Show 22 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use